ASCO 2024 - MedTalk: Dr. Stephanie Wong on PARPi Eligibility in Women with Newly Diagnosed Invasive Breast Cancer

Join Dr. Stephanie Wong at ASCO as she presents data on PARP inhibitor eligibility in women with newly diagnosed invasive breast cancer. This research is part of the GREAT AGATA Study, a universal genetic testing initiative aimed at improving patient outcomes.